ETHZ
Price
$5.41
Change
+$0.26 (+5.05%)
Updated
Jan 14 closing price
Capitalization
102.67M
Intraday BUY SELL Signals
PRQR
Price
$1.65
Change
+$0.01 (+0.61%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
172.77M
35 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ETHZ vs PRQR

Header iconETHZ vs PRQR Comparison
Open Charts ETHZ vs PRQRBanner chart's image
ETHZilla
Price$5.41
Change+$0.26 (+5.05%)
Volume$866.45K
Capitalization102.67M
ProQR Therapeutics
Price$1.65
Change+$0.01 (+0.61%)
Volume$5.03K
Capitalization172.77M
ETHZ vs PRQR Comparison Chart in %
ETHZ
Daily Signal:
Gain/Loss:
PRQR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ETHZ vs. PRQR commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETHZ is a Hold and PRQR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (ETHZ: $5.41 vs. PRQR: $1.64)
Brand notoriety: ETHZ and PRQR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ETHZ: 93% vs. PRQR: 114%
Market capitalization -- ETHZ: $102.67M vs. PRQR: $172.77M
ETHZ [@Biotechnology] is valued at $102.67M. PRQR’s [@Biotechnology] market capitalization is $172.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ETHZ’s FA Score shows that 0 FA rating(s) are green whilePRQR’s FA Score has 1 green FA rating(s).

  • ETHZ’s FA Score: 0 green, 5 red.
  • PRQR’s FA Score: 1 green, 4 red.
According to our system of comparison, both ETHZ and PRQR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ETHZ’s TA Score shows that 6 TA indicator(s) are bullish while PRQR’s TA Score has 4 bullish TA indicator(s).

  • ETHZ’s TA Score: 6 bullish, 2 bearish.
  • PRQR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ETHZ is a better buy in the short-term than PRQR.

Price Growth

ETHZ (@Biotechnology) experienced а +8.20% price change this week, while PRQR (@Biotechnology) price change was -24.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.47%. For the same industry, the average monthly price growth was +3.44%, and the average quarterly price growth was +44.89%.

Reported Earning Dates

PRQR is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (+0.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRQR($173M) has a higher market cap than ETHZ($103M). ETHZ YTD gains are higher at: 10.408 vs. PRQR (-18.812). PRQR has higher annual earnings (EBITDA): -38.15M vs. ETHZ (-216.47M). PRQR has more cash in the bank: 107M vs. ETHZ (53.3M). PRQR has less debt than ETHZ: PRQR (16.5M) vs ETHZ (547M). PRQR has higher revenues than ETHZ: PRQR (15.5M) vs ETHZ (4.11M).
ETHZPRQRETHZ / PRQR
Capitalization103M173M60%
EBITDA-216.47M-38.15M567%
Gain YTD10.408-18.812-55%
P/E RatioN/AN/A-
Revenue4.11M15.5M27%
Total Cash53.3M107M50%
Total Debt547M16.5M3,315%
FUNDAMENTALS RATINGS
ETHZ vs PRQR: Fundamental Ratings
ETHZ
PRQR
OUTLOOK RATING
1..100
5061
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
24
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
9689
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRQR's Valuation (24) in the Biotechnology industry is in the same range as ETHZ (44) in the Financial Conglomerates industry. This means that PRQR’s stock grew similarly to ETHZ’s over the last 12 months.

PRQR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ETHZ (100) in the Financial Conglomerates industry. This means that PRQR’s stock grew similarly to ETHZ’s over the last 12 months.

PRQR's SMR Rating (99) in the Biotechnology industry is in the same range as ETHZ (99) in the Financial Conglomerates industry. This means that PRQR’s stock grew similarly to ETHZ’s over the last 12 months.

PRQR's Price Growth Rating (89) in the Biotechnology industry is in the same range as ETHZ (96) in the Financial Conglomerates industry. This means that PRQR’s stock grew similarly to ETHZ’s over the last 12 months.

ETHZ's P/E Growth Rating (97) in the Financial Conglomerates industry is in the same range as PRQR (100) in the Biotechnology industry. This means that ETHZ’s stock grew similarly to PRQR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ETHZPRQR
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 8 days ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ETHZ
Daily Signal:
Gain/Loss:
PRQR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TROUF0.020.01
+64.86%
Troubadour Resources Inc.
SNPHY10.980.21
+1.95%
Santen Pharmaceutical Co., Ltd.
AVLNF0.06N/A
+1.93%
Avalon Advanced Materials Inc.
IOBCF15.20N/A
N/A
Ion Beam Applications S.A.
AHCHF2.76N/A
N/A
Anhui Conch Cement Co., Ltd.

ETHZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETHZ has been loosely correlated with PTN. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ETHZ jumps, then PTN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETHZ
1D Price
Change %
ETHZ100%
+5.05%
PTN - ETHZ
52%
Loosely correlated
-2.27%
JSPR - ETHZ
41%
Loosely correlated
+3.85%
PRQR - ETHZ
38%
Loosely correlated
N/A
REPL - ETHZ
34%
Loosely correlated
-4.10%
ANRO - ETHZ
34%
Loosely correlated
+4.00%
More

PRQR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRQR has been loosely correlated with RGNX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PRQR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRQR
1D Price
Change %
PRQR100%
-2.38%
RGNX - PRQR
49%
Loosely correlated
-0.20%
BEAM - PRQR
46%
Loosely correlated
+2.55%
RNAC - PRQR
44%
Loosely correlated
+5.36%
ETHZ - PRQR
44%
Loosely correlated
+3.62%
DNLI - PRQR
44%
Loosely correlated
+0.89%
More